Age- and region-specific gut microbiota dysbiosis in axial spondyloarthritis: a systematic review and meta-analysis

中轴型脊柱关节炎患者肠道菌群失调的年龄和地域特异性:系统评价和荟萃分析

阅读:1

Abstract

BACKGROUND: Axial spondyloarthritis (axSpA) is a chronic inflammatory disease affecting the spine and sacroiliac joints. Emerging evidence suggests that the gut microbiota may contribute to its pathogenesis, but findings on microbial diversity and composition remain inconsistent. METHODS: We systematically searched PubMed, Embase, Web of Science, and the Cochrane Library to identify studies comparing the gut microbiota between adults with axSpA and healthy controls. α-Diversity (Observed richness, Shannon, Simpson, Chao1, ACE) and microbial composition at the phylum level were extracted. Random-effects meta-analyses were performed using standardized mean differences (SMDs), with subgroup analyses and robustness checks (prespecified sensitivity and leave-one-out analyses). RESULTS: Twenty-five studies (n = 1639) were included. Compared with controls, axSpA was associated with lower α-diversity for Observed richness (SMD = -0.59, P = 0.04), Shannon (SMD = -0.19, P = 0.03), and Chao1 (SMD = -0.51, P = 0.02), while Simpson (SMD = -0.23, P = 0.12) and ACE (SMD = 0.42, P = 0.14) showed no significant differences. In age-stratified analyses, reductions were more apparent in participants >40 years (Shannon: SMD = -0.38, P = 0.002; Simpson: SMD = -0.50, P = 0.001). Sensitivity and leave-one-out analyses were directionally consistent; however, observed richness and Shannon became non-significant after excluding non-comparable datasets. Phylum-level findings were summarized descriptively, suggesting lower Bacteroidota and Actinobacteriota and higher Proteobacteria in axSpA. CONCLUSION: axSpA is associated with reduced α-diversity and compositional shifts in gut microbiota, but the magnitude of effects varies across studies. Heterogeneity and methodological differences warrant cautious interpretation. Longitudinal and functional studies are needed to clarify causality and therapeutic implications. SYSTEMATIC REVIEW REGISTRATION: https://www.crd.york.ac.uk/prospero/, identifier CRD420251089098.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。